Thompson Medical Group has acquired FV Hospital in Vietnam for USD 381.4 million, marking a significant milestone as the largest healthcare acquisition in the country and Southeast Asia since 2020.

Information on the Target

Thompson Medical Group has successfully entered into an agreement to acquire FV Hospital, a prominent healthcare facilities provider based in Vietnam, for a total consideration of USD 381.4 million. This transaction marks a significant milestone as it constitutes Vietnam's largest healthcare acquisition to date, as well as the largest in Southeast Asia since 2020. The acquisition includes an initial payment of approximately USD 359.6 million, complemented by an earnout of USD 21.8 million, reflecting both the value of FV Hospital and its promising growth potential.

FV Hospital, also known as Far East Medical Vietnam, reported revenues of VND 1,930.6 billion (roughly USD 81.6 million) and an EBITDA of VND 463.7 billion (approximately USD 19.5 million) for the fiscal year 2022. These figures translate into a notable enterprise value of USD 328.5 million, demonstrating a robust EBITDA multiple of 16.8x, positioning FV Hospital as a strategic asset within the region's healthcare landscape.

Industry Overview in Vietnam

The healthcare industry in Vietnam is on an upward trajectory, driven by a combination of rising healthcare demands, increased investment, and a growing private sector. Vietnam's population is increasingly open to utilizing private healthca

View Source

Similar Deals

DKSH Technology Biomedic Science Material Joint Stock Company

2025

Merger Bio Diagnostics & Testing Vietnam
GE HealthCare Intelerad

2026

Merger Medical Imaging Systems United States of America
Novartis AG Avidity Biosciences, Inc.

2026

Merger Proprietary & Advanced Pharmaceuticals United States of America
XenoTherapeutics, Inc. Repare Therapeutics Inc.

2026

Merger Bio Therapeutic Drugs United States of America
Eli Lilly Ventyx Bioscences

2026

Merger Bio Therapeutic Drugs United States of America
MSD (Merck & Co., Inc.) Cidara Therapeutics, Inc.

2026

Merger Proprietary & Advanced Pharmaceuticals United States of America

Thomson Medical Group

invested in

FV Hospital

in 2023

in a Merger deal

Disclosed details

Transaction Size: $381M

Revenue: $82M

EBITDA: $20M

Enterprise Value: $329M

Equity Value: $381M


Multiples

EV/EBITDA: 16.8x

EV/Revenue: 4.0x

P/Revenue: 4.7x

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert